SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-23-301182
Filing Date
2023-12-21
Accepted
2023-12-21 16:05:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D d585841dsc13d.htm SC 13D 36123
  Complete submission text file 0001193125-23-301182.txt   37777
Mailing Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011
Business Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011 (877) 237-5020
Neurogene Inc. (Subject) CIK: 0001404644 (see all company filings)

IRS No.: 980542593 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88050 | Film No.: 231505318
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O INTERCEPT PHARMACEUTICALS, INC. 450 W. 15TH ST., STE. 505 NEW YORK NY 10011
Business Address
McMinn Rachel (Filed by) CIK: 0001606302 (see all company filings)

Type: SC 13D